Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Patheon, Inc. | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Patheon, Inc.

Mark Kontny, Ph.D. has joined Patheon, Inc. as president of Global Pharmaceutical Development Services (PDS) and as its chief scientific officer.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Mark Kontny, Ph.D. has joined Patheon, Inc. as president of Global Pharmaceutical Development Services (PDS) and as its chief scientific officer. Dr. Kontny joins the company from Abbott Laboratories, where he was divisional vice president, Global Pharmaceutical and Analytical Sciences, for the global pharmaceutical R&D organization.

“Mark has developed a well deserved reputation for combining strong technical abilities with excellent leadership skills. We look forward to him quickly integrating into the Patheon leadership team and helping us drive our PDS business to an even higher performance level,” said Wes Wheeler, Patheon’s chief executive officer and president.

“I am delighted to join Patheon and look forward to leading the PDS organization to provide best in class development services to accelerate customer molecules to market,” said Dr. Kontny.

Dr. Kontny has nearly 25 years of industry experience having held positions of increasing responsibility at Ventaira Pharmaceuticals, Boehringer-Ingelheim, Monsanto-G.D. Searle, Pharmacia and Pfizer.

Click here to learn more about Patheon

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters